Prithvi Shaw and two other domestic cricketers have received suspensions by the Board of Control for Cricket in India for doping violations.
BCCI published a release declaring that the 19-year-old Test opener failed a doping test conducted back in February this year during the Syed Mushtaq Ali Trophy.
Shaw had "inadvertently ingested a prohibited substance, which can be commonly found in cough syrup", the BCCI release stated.
The Mumbai cricketer had provided a urine sample as part of the anti-doping testing program just before the T20 match against Punjab on February 22.
The sample was found to contain the substance Terbutaline, which is mentioned on the WADA Prohibited List of Substances.
Subsequently, Shaw was charged on July 16 under the BCCI Anti-Doping Rules (ADR) Article 2.1 and was provisionally suspended from cricket.
He admitted the offense but claimed it was unintended since he was consuming an over-the-counter syrup for his cough.
Based on this explanation given by the youngster, BCCI ruled out the possibility of using the substance as a performance enhancer and gave him an eight-month suspension that back-dates to the time of the sample collection.
The back-dated eight-month suspension means Shaw will be ineligible to return to cricket duty until November 15.
However, he can use the training facilities of the BCCI from September 15 onwards according to the guidelines.
The other two cricketers suspended for minor inadvertent doping violations include Divya Gajraj and Akshay Dullarwar.